Plasma Carboxypeptidase B as a Predictor for Disease Severity and Response
    1.
    发明申请
    Plasma Carboxypeptidase B as a Predictor for Disease Severity and Response 审中-公开
    血浆羧肽酶B作为疾病严重程度和反应的预测因子

    公开(公告)号:US20130052186A1

    公开(公告)日:2013-02-28

    申请号:US13492099

    申请日:2012-06-08

    摘要: Compositions and methods are provided for prognostic classification of individuals into groups that are informative of the individual's likelihood of developing severe disease associated with undesirable complement activation. Individuals having one or both alleles for a more stable or active carboxypeptidase B variant have a reduced propensity for developing severe disease. The presence of the protective variant may be identified through any suitable method.

    摘要翻译: 提供组合物和方法用于将个体预测分类成组,其中提供个体与发生与不期望的补体活化相关的严重疾病的可能性的可能性。 具有一个或两个更稳定或活性的羧肽酶B变体的等位基因的个体具有降低的发展严重疾病的倾向。 可以通过任何合适的方法鉴定保护性变体的存在。